Topics

Polycystic Kidney Disease Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975

05:40 EST 2 Feb 2020 | BioPortfolio Reports

FirstView Market Insight Polycystic Kidney Disease Market Review, Epidemiology And Market Forecast 2029 provides in depth understanding of historical and forecasted epidemiology along with the detailed market insights.The report covers detailed information on the disease, treatment algorithm, existing treatment and upcoming treatment regimens, unmet needs, market drivers, market barriers, sales trend and market revenue during study period 20182029.Polycystic kidney disease is a disorder that affects the kidneys and other organs. Clusters of fluidfilled sacs, called cysts, develop in the kidneys and interfere with their ability to filter waste products from the blood. The growth of cysts causes the kidneys to become enlarged and can lead to kidney failure. Cysts may also develop in other organs, particularly the liver.

Frequent complications of polycystic kidney disease include hypertension, pain in the back or sides, hematuria, recurrent urinary tract infections, kidney stones, and aneurysms.

The two major forms of polycystic kidney disease are distinguished by the usual age of onset and the pattern in which it is passed through families. The autosomal dominant form sometimes called ADPKD has signs and symptoms that typically begin in adulthood, although cysts in the kidney are often present from birth or childhood. Autosomal dominant polycystic kidney disease can be further divided into type 1 and type 2, depending on the genetic cause. The autosomal recessive form of polycystic kidney disease sometimes called ARPKD is much rarer and is often lethal early in life. The signs and symptoms of this condition are usually apparent at birth or in early infancy.Overview

This report contains comprehensive overview of disease including disease definition, classification, symptoms, etiology, pathophysiology, diagnostic trends, as well as details about treatment algorithms and treatment guidelines

Epidemiology Forecast

This section encompasses information on the incidence and prevalence of disease in EU5, US Japan. It also provides historical, current and forecasted estimates of diagnosed/treatable patient population.

Existing and upcoming treatment landscape

Captures the evolution of treatment paradigm including the current and emerging drug therapies. Provides information on the clinical trial results, mechanism of action, route of administration, therapeutic positioning, regulatory milestones and patent exclusivity. It gives insight into the potential therapeutic targets for drug development. The section also covers major events and latest happenings, deals and collaborations.

Market Size

This section of report will address the major issues, on the size and total addressable market share. This will help the companies to understand and visualize their business prospects and make major decisions based on the historical, current and forecasted market share across the globe. Analyze the commercial potential of the product as well as the disease/therapy area.


Market Trends Unmet needs

This section of the report helps to understand the market trend and opportunities by analyzing the impact of current therapies on the market, current and future unmet needs, drivers and barriers and demand of better technology. This is determined by analyzing the impact of various factors such as mechanism of action, route, cost of therapy, patient segmentation, existing available treatments, compliance and need of the market, expected launch timelines, competitors, brand value and KOLs perception.


List of products

Benazepril Lotensin

Captopril.

Enalapril Vasotec

Fosinopril.

Lisinopril Prinivil, Zestril

Moexipril.

Perindopril.

Quinapril Accupril

Azilsartan Edarbi

Candesartan Atacand

Eprosartan.

Irbesartan Avapro

Losartan Cozaar

Olmesartan Benicar

Telmisartan Micardis

Valsartan Diovan

Original Article: Polycystic Kidney Disease Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975

NEXT ARTICLE

More From BioPortfolio on "Polycystic Kidney Disease Market Review, Epidemiology And Market Forecast 2029 [Published by First View Insight] Prices from USD $2975"

Quick Search

Relevant Topics

Renal disease
Chronic kidney disease (CKD), also known as chronic renal disease, is a progressive loss in renal function over a period of months or years. The symptoms of worsening kidney function are non-specific, and might include feeling generally unwell and experi...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...